Ksenia Boriskina

Articles

Article: BONE MARROW TRANSPLANTATION. 2021;56(3):614-621
Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT
Loke J; Labopin M; Craddock C; Niederwieser D; Cornelissen J; Afansayev B; Jindra P; Maertens J; Blaise D; Boriskina K; Gramatzki M; Ganser A; Savani B; Mohty M; Nagler A
Article: BONE MARROW TRANSPLANTATION. 2020;55(7):1255-1263
Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients
Swartling L; Norden R; Samuelsson E; Boriskina K; Valentini D; Westin J; Norder H; Sparrelid E; Ljungman P

Letter: LEUKEMIA AND LYMPHOMA. 2022;63(3):755-758
Limited benefit in patients with MDS receiving venetoclax and azacitidine as a bridge to allogeneic stem cell transplantation
Jadersten M; Boriskina K; Lindholm C; Westrom S; Cavelier L; Hellstrom-Lindberg E; Mielke S; Tobiasson M